This document aims to provide guidance for public health and laboratory experts in identifying human infections with animal influenza viruses as early as possible to provide early warning and inform risk assessments and public health measures.
Clusters and outbreaks of hepatitis A virus (HAV) genotype IB with four unique but closely related HAV sequences have been reported in six European Union (EU) countries and in the United Kingdom (UK).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 August-3 September 2022 and includes updates on COVID-19, monkeypox, West Nile virus, increase in hepatitis cases of unknown aetiology in children, Vibrio, and poliomyelitis.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-20 August 2022 and includes updates on COVID-19, monkeypox, West Nile virus infection, swine influenza, Vibrio growth, poliovirus and poliomyelitis.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 August 2022 and includes updates on West Nile virus infection, COVID-19, monkeypox, measles, Crimean-Congo haemorrhagic fever, Langya henipavirus, dengue, mass gatherings at the Birmingham 2022 commonwealth games, Vibrio growth, swine influenza and polio.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24 -30 July and includes updates on COVID-19, monkeypox, West Nile virus, increase in hepatitis of unknown aetiology in children, mass gatherings in the Birmingham 2022 Commonwealth games, Vibrio growth, Marburg disease, Chikungunya, dengue, and wild poliovirus.
For 2020, 29 EU/EEA Member States reported 14 428 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases (14 137) corresponds to a crude rate of 4.2 cases per 100 000 population.
In 2020, 13 914 cases of hepatitis C were reported in 28 EU/EEA Member States. Excluding countries that only reported acute cases leaves 13 901 cases, which corresponds to a crude rate of 3.9 cases per 100 000 population.